ArticleJournal of molecular medicine (Berlin, Germany)2024

Polo-like kinase 2 targeting as novel strategy to sensitize mutant p53-expressing tumor cells to anticancer treatments.

Fabio Valenti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.